Health Condition 1: null- Patients suffering from Prameha ( Diabetes Mellitus )
Conditions
Interventions
Intervention1: Quassia amara Linn. capsules: (1.5 g BD with lukewarm water) exercise and Pathya, 2 months
Control Intervention1: Any allopathic medicine: dose as recommended by
modern physician along
Sponsors
IPGTRA Gujarat Ayurved University
Eligibility
Inclusion criteria
Inclusion criteria: INCLUSION CRITERIA Age between 40 years to 70 years Patients having chief and associated complaints of Apathyanimittaja Prameha Known patient of Type II diabetes mellitus and also the patients preliminarily diagnosed Type II diabetes mellitus on the basis of signs and symptoms of the disease will be confirmed by FBS and PPBS DIAGNOSIS CRITERIA Standard criteria of National Diabetes Data group and the World Health Organization for Diabetes Mellitus will be adopted as follow Symptoms of diabetes Mellitus Random blood glucose concentration greater than 200 mg dL OR Fasting blood glucose greater than 126mgdL OR Two hours blood glucose greater than 200 mgdL during an oral glucose tolerance test Adopted by American Diabetic Association
Exclusion criteria
Exclusion criteria: EXCLUSION CRITERIA Age below 40 years & above 70 years Patients of Sahaja Prameha and having bala and dhatukshaya and Type I diabetes mellitus Patients suffering from Malignant and accelerated hypertension CVS disorder CAD Pregnant woman and planning to be pregnant within six months Lactating mother Secondary diabetes mellitus diabetic ketosis CNS disorder eg encephalopathy Patient undergoing regular treatment for any other severe illness and also patients suffering from tuberculosis carcinoma and HIV positive patients including endocrine disorders like Thyrotoxicosis Cushing Syndrome etc
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The efficacy of treatment will be assessed on the basis of relief in signs and symptoms Evaluation of biochemical parameters such as FBS, PPBS in both groups along with Hematological, Urine routine and microscopic examination before and after the treatment. S. Insulin and Glycosulated haemoglobin before and after the treatment.(if possible )Timepoint: The efficacy of treatment will be assessed on the basis of relief in signs and symptoms after 2 months of treatment Evaluation of biochemical parameters such as FBS, PPBS in both groups along with Hematological, Urine routine and microscopic examination before and after the treatment. S. Insulin and Glycosulated haemoglobin before and after the treatment.(if possible ) | — |
Secondary
| Measure | Time frame |
|---|---|
| exacerbation in signs and symptomsTimepoint: 4 weeks | — |
Countries
India
Contacts
Public ContactDr Mandip Goyal
IPGTRA, Gujarat Ayurved University Jamnagar
Outcome results
None listed